Completed

Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

What is being collected

Data Collection

Collected from past medical records and data - Retrospective

Who is being recruted

Cataract

+ Eye Diseases

+ Lens Diseases

+10 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.

Observational

Study Start: September 2023

See protocol details

Summary

Principal SponsorJohnson & Johnson Surgical Vision, Inc.

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: September 11, 2023

Actual date on which the first participant was enrolled.

Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.

Official TitleEvaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

NCT05991960

Principal SponsorJohnson & Johnson Surgical Vision, Inc.

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

96 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

CataractEye DiseasesLens Diseases

Criteria

4 inclusion criteria required to participate

Previously bilaterally implanted with TECNIS Odyssey IOL, following cataract extraction;

Enrollment at least 21 days after second eye surgery;

Clear intraocular media in each eye.

Signed consent and data protection documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.

6 exclusion criteria prevent from participating

Concurrent participation in an interventional clinical trial during the time from which the data will be collected;

Use of systemic or ocular medication that may affect vision;

Prior corneal refractive surgery in each eye (i.e., LASIK, PRK, SMILE, RK, CK); NOTE: Limbal relaxing incisions (LRI) are permissible as planned at the time of surgery (intraoperatively) but not postoperatively within the retrospective analysis window;

Ongoing adverse events in each eye that might impact outcomes during the study visit as determined by the investigator;

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 12 locations

Suspended

Assil Eye Institute

Beverly Hills, United StatesOpen Assil Eye Institute in Google Maps

Suspended

The Eye Institute of West Florida

Largo, United States

Suspended

Center for Sight

Sarasota, United States

Suspended

Aloha Vision Consultants

Honolulu, United States

Completed12 Study Centers